ReviewDer Nervenarzt2010
[The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness].
Review in Der Nervenarzt, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Does helping mothers in multigenerational ADHD also help children in the long run? 2-year follow-up from baseline of the AIMAC randomized controlled multicentre trial.European child & adolescent psychiatry · 2020Article
- Prevalence of ADHD in Accident Victims: Results of the PRADA Study.Journal of clinical medicine · 2019Article
- Accident patterns in trauma surgery patients with and without self-reported ADHD.Journal of neural transmission (Vienna, Austria : 1996) · 2019Article
- Cost effectiveness of optimal treatment of ADHD in Israel: a suggestion for national policy.Health economics review · 2019Article
- The cost incurred by victims of bullying from a societal perspective: estimates based on a German online survey of adolescents.European child & adolescent psychiatry · 2019Article
- Article
- Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents.International journal of mental health systems · 2017Article
- The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.Frontiers in pediatrics · 2017Article
- Preschool hyperactivity is associated with long-term economic burden: evidence from a longitudinal health economic analysis of costs incurred across childhood, adolescence and young adulthood.Journal of child psychology and psychiatry, and allied disciplines · 2015Article
- Annual research review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders.Journal of child psychology and psychiatry, and allied disciplines · 2014Review
- Treatment costs of attention deficit hyperactivity disorder in Germany.The European journal of health economics : HEPAC : health economics in prevention and care · 2013Article
- [Survey of attention deficit hyperactivity disorder in adults].Der Nervenarzt · 2012Review
- [The health economics of attention deficit hyperactivity disorder in Germany. Part 2: Therapeutic options and their cost-effectiveness].Der Nervenarzt · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the German region of Nordbaden, 5% of children (aged 7-12 years) and 1.3% of adolescents (aged 13-19 years) were diagnosed with attention deficit hyperactivity disorder (ADHD) in 2003. About two thirds of these patients were not seen by a physician specialized in psychiatry. Now the National Association of Statutory Health Insurance Physicians in Germany (Kassenaerztliche Bundesvereinigung, KBV) has developed a proposal for the integrated provision of care for these patients, combining a guidelines-oriented multidisciplinary approach with a system of quality assurance. Against this background, currently available ADHD-related data are presented, covering epidemiology, comorbidity and differential diagnosis, health care utilization, and cost of illness. According to administrative data analyses from Nordbaden, direct medical costs for patients with ADHD, from the perspective of statutory health insurance (SHI), exceed those of matched controls by a factor of >2.5. On this basis, ADHD-related expenditures of the German SHI may be estimated at around EUR 260 million in 2003, and almost certainly will have continued to grow further since. In addition to this, a diagnosis of ADHD is associated with substantial indirect cost. Although the literature on the burden of ADHD is incomplete, it seems plausible that the cost of illness might be comparable to that reported for alcohol and addiction disorders. Thus we anticipate an increasing relevance of formal health economic evaluations of health care programs offered to patients with ADHD.
Indexed as
Identifiers
20232510What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.